SG Americas Securities, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$125
-99.8%
10,3700.0%0.00%
+100.0%
Q3 2022$67,000
-68.5%
10,370
-77.7%
0.00%
-50.0%
Q2 2022$213,000
+73.2%
46,532
+439.1%
0.00%
+100.0%
Q4 2021$123,000
-58.7%
8,631
-36.3%
0.00%0.0%
Q3 2021$298,00013,5410.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,355,925$2,955,9172.56%
Susquehanna International Group Ltd. 113,526$247,4870.14%
XTX Topco Ltd 151,620$330,5320.07%
Corsair Capital Management 47,256$103,0180.04%
Diametric Capital, LP 14,314$31,2050.02%
Draper Asset Management, LLC 5,320$11,5980.02%
ETF MANAGERS GROUP, LLC 68,940$150,2890.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$12,2670.00%
TWO SIGMA INVESTMENTS, LP 506,255$1,103,6360.00%
Apollon Wealth Management, LLC 20,000$43,6000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders